G

GemPharmatech Co Ltd
SSE:688046

Watchlist Manager
GemPharmatech Co Ltd
SSE:688046
Watchlist
Price: 13.7 CNY 3.16%
Market Cap: 5.6B CNY
Have any thoughts about
GemPharmatech Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
GemPharmatech Co Ltd

Current Assets 1.7B
Cash & Short-Term Investments 1.3B
Receivables 380.8m
Other Current Assets 61m
Non-Current Assets 870.1m
Long-Term Investments 99m
PP&E 638.1m
Intangibles 54.6m
Other Non-Current Assets 78.5m
Current Liabilities 426.6m
Accounts Payable 94.6m
Accrued Liabilities 33.5m
Short-Term Debt 108.1m
Other Current Liabilities 190.5m
Non-Current Liabilities 74.3m
Long-Term Debt 37.4m
Other Non-Current Liabilities 37m

Balance Sheet
GemPharmatech Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
23
222
524
294
422
560
Cash
23
222
524
294
422
560
Short-Term Investments
30
27
0
206
791
758
Total Receivables
33
67
104
172
201
288
Accounts Receivables
30
64
91
119
185
269
Other Receivables
3
3
13
54
16
18
Inventory
14
12
17
30
49
47
Other Current Assets
0
1
2
5
3
5
Total Current Assets
100
329
647
707
1 467
1 658
PP&E Net
3
30
165
238
395
629
PP&E Gross
3
30
165
238
395
629
Accumulated Depreciation
1
2
6
19
38
68
Intangible Assets
1
22
41
50
49
47
Long-Term Investments
0
0
0
30
69
176
Other Long-Term Assets
1
7
30
29
275
69
Total Assets
105
N/A
388
+271%
883
+128%
1 054
+19%
2 254
+114%
2 578
+14%
Liabilities
Accounts Payable
27
23
41
62
51
102
Accrued Liabilities
5
18
22
34
43
45
Short-Term Debt
2
16
10
5
12
76
Current Portion of Long-Term Debt
0
0
0
0
3
9
Other Current Liabilities
28
66
76
90
105
134
Total Current Liabilities
62
123
149
192
214
366
Long-Term Debt
0
0
0
20
3
36
Deferred Income Tax
0
1
6
7
10
9
Minority Interest
0
0
0
0
0
0
Other Liabilities
15
23
70
50
49
41
Total Liabilities
77
N/A
148
+92%
226
+53%
269
+19%
276
+3%
453
+64%
Equity
Common Stock
10
12
360
360
410
410
Retained Earnings
6
29
24
149
313
455
Additional Paid In Capital
24
200
274
277
1 254
1 258
Other Equity
0
0
0
0
1
1
Total Equity
28
N/A
240
+767%
657
+173%
786
+20%
1 978
+152%
2 125
+7%
Total Liabilities & Equity
105
N/A
388
+271%
883
+128%
1 054
+19%
2 254
+114%
2 578
+14%
Shares Outstanding
Common Shares Outstanding
410
410
410
410
410
410

See Also

Discover More